1. Negoita, S, Feuer, EJ, Mariotto, A, et al. Annual report to the nation on the status of cancer, part II: recent changes in prostate cancer trends and disease characteristics. Cancer 2018; 124: 2801–2814.
Google Scholar | Crossref | Medline2. Chung, E. Management of treatment-related sexual complications in cancer care: evidence for erectile function recovery and penile rehabilitation after radical prostatectomy in prostate cancer survivorship. Expert Rev Qual Life Cancer Care 2017; 2: 279–286.
Google Scholar | Crossref3. Wallis, CJD, Saskin, R, Choo, R, et al. Surgery versus radiotherapy for clinically-localised prostate cancer: a systematic review and meta-analysis. Eur Urol 2016; 70: 21–30.
Google Scholar | Crossref | Medline4. Gaither, TW, Awad, MA, Osterberg, EC, et al. The natural history of erectile dysfunction after prostatic radiotherapy: a systematic review and meta-analysis. J Sex Med 2017; 14: 1071–1078.
Google Scholar | Crossref | Medline5. Philippou, YA, Jung, JH, Steggall, MH, et al. Penile rehabilitation for postprostatectomy erectile dysfunction. Cochrane Database Syst Rev 2018; 10: CD012414.
Google Scholar6. Wang, X, Wang, X, Liu, et al. Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy. PLoS One 2014; 9: e91327.
Google Scholar7. Limoncin, E, Gravina, GL, Corona, G, et al. Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis. Andrology 2017; 5: 863–872.
Google Scholar | Crossref | Medline8. Chung, E, Brock, G. Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors. J Sex Med 2013; 10(Suppl. 1): 102–111.
Google Scholar | Crossref | Medline9. Chung, E, Gillman, M. Prostate cancer survivorship: a review of current literature in erectile dysfunction and the concept of penile rehabilitation following prostate cancer therapy. Med J Aust 2014; 200: 582–585.
Google Scholar | Crossref | Medline10. Frey, A, Sonksen, J, Fode, M. Low-intensity extracorporeal shockwave therapy in the treatment of postprostatectomy erectile dysfunction: a pilot study. Scand J Urol 2016; 50: 123–127.
Google Scholar | Crossref | Medline11. Zewin, TS, El-Assmy, A, Harraz, et al. Efficacy and safety of low-intensity shockwave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial. Int Urol Nephrol 2018; 50: 2007–2014.
Google Scholar | Crossref | Medline12. Baccaglini, W, Pazeto, CL, Barros, EAC, et al. The role of the low-intensity extracorporeal shockwave therapy on penile rehabilitation after radical prostatectomy: a randomised clinical trial. J Sex Med 2020; 17: 688–694.
Google Scholar | Crossref | Medline13. Yiou, R, Hamidou, L, Birebent, B, et al. Safety of intracavernous bone marrow-mononuclear cells for postradical prostatectomy erectile dysfunction: an open dose-escalation pilot study. Eur Urol 2016; 69: 988–991.
Google Scholar | Crossref | Medline14. Haahr, MK, Jensen, CH, Toyserkani, NM, et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. EBioMedicine 2016; 5: 204–210.
Google Scholar | Crossref | Medline15. Haahr, MK, Harken Jensen, C, Toyserkani, NM, et al. A 12-month follow-up after a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. Urology 2018; 121: 203.e6–203.e13.
Google Scholar | Crossref | Medline16. Protogerou, V, Michalopoulos, E, Mallis, P, et al. Administration of adipose derived mesenchymal stem cells and platelet lysate in erectile dysfunction: a single center pilot study. Bioengineering 2019; 6: 21.
Google Scholar | Crossref17. Matz, EL, Pearlman, AM, Terlecki, RP. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol 2018; 59: 61–65.
Google Scholar | Crossref | Medline18. Phase 2A clinical trial evaluating the potential activity and safety of hMaxi-K gene for ED , https://clinicaltrials.gov/ct2/show/NCT02713789 (accessed 5 March 2021).
Google Scholar19. Souza Trindade, JC, Viterbo, F, Trindade, AP, et al. Long-term follow-up of treatment of erectile dysfunction after radical prostatectomy using nerve grafts and end-to-side somatic-to-autonomic neurorraphy: a new technique. BJU Int 2017; 119: 948–954.
Google Scholar | Crossref | Medline20. Reece, JC, Dangerfield, DC, Coombs, CJ. End-to-side somatic-to-autonomic nerve grafting to restore erectile function and improve quality of life after radical prostatectomy. Eur Urol 2019; 76: 189–196.
Google Scholar | Crossref | Medline21. Capogrosso, P, Frey, A, Jensen, CFS, et al. Low-intensity shock wave therapy in sexual medicine- clinical recommendations from the European Society of Sexual Medicine (ESSM). J Sex Med 2019; 16: 1490–1505.
Google Scholar | Crossref | Medline22. Chung, E, Lee, J, Liu, CC, et al. Clinical practice guideline recommendation on the use of low intensity extracorporeal shock wave therapy and low intensity pulsed ultrasound shock wave therapy to treat erectile dysfunction: the Asia-Pacific Society for Sexual Medicine position statement. World J Mens Health 2020; 39: 1–8.
Google Scholar | Crossref | Medline23. Chung, E, Wang, J. A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction. Expert Rev Med Devices 2017; 14: 929–934.
Google Scholar | Crossref | Medline24. Campbell, JD, Trock, BJ, Oppenheim, AR, et al. Meta-analysis of randomized controlled trials that assess the efficacy of low-intensity shockwave therapy for the treatment of erectile dysfunction. Ther Adv Urol 2019; 11: 1756287219838364.
Google Scholar | SAGE Journals25. Clavijo, RI, Kohn, TP, Kohn, JR, et al. Effects of low-intensity extracorporeal shockwave therapy on erectile dysfunction: a systematic review and meta-analysis. J Sex Med 2017; 14: 27–35.
Google Scholar | Crossref | Medline26. Man, L, Li, G. Low-intensity extracorporeal shock wave therapy for erectile dysfunction: a systematic review and meta-analysis. Urology 2018; 119: 97–103.
Google Scholar | Crossref | Medline27. Zou, ZJ, Tang, LY, Liu, ZH, et al. Short-term efficacy and safety of low-intensity extracorporeal shock wave therapy in erectile dysfunction: a systematic review and meta-analysis. Int Braz J Urol 2017; 43: 805–821.
Google Scholar | Crossref | Medline28. Li, H, Matheu, MP, Sun, F, et al. Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model. J Sex Med 2016; 13: 22–32.
Google Scholar | Crossref | Medline | ISI29. Chen, KC, Minor, TX, Rahman, NU, et al. The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model of neurogenic impotence. BJU Int 2005; 95: 1077–1080.
Google Scholar | Crossref | Medline30. Zou, ZJ, Liang, JY, Liu, ZH, et al. Low-intensity extracorporeal shockwave therapy for erectile dysfunction after radical prostatectomy: a review of preclinical studies. Int J Impot Res 2018; 30: 1–7.
Google Scholar | Crossref | Medline31. Usta, M, Gabrielson, AT, Bivalacqua, TK. Low-intensity extracorporeal shockwave therapy for erectile dysfunction following radical prostatectomy: a critical review. Int J Impot Res 2019; 31: 231–238.
Google Scholar | Crossref | Medline32. Chung, E, Cartmill, R. Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single arm prospective clinical trial. BJU Int 2015; 115(Suppl. 5): 46–49.
Google Scholar | Crossref | Medline33. Fojecki, GL, Tiessen, S, Osther, PJ. Effect of low-energy linear shockwave therapy on erectile dysfunction-a double-blinded, sham-controlled, randomized clinical trial. J Sex Med 2017; 14: 106–112.
Google Scholar | Crossref | Medline34. Lin, CS, Xin, ZC, Wang, Z, et al. Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev 2012; 21: 343–351.
Google Scholar | Crossref | Medline | ISI35. Lin, CS, Xin, Z, Dai, J, et al. Stem-cell based therapy for erectile dysfunction. Expert Opin Biol Ther 2013; 13: 1585–1597.
Google Scholar | Crossref | Medline36. Chung, E. Stem-cell-based therapy in the file of urology: a review of stem cell basic science, clinical applications and future directions in the treatment of various sexual and urinary conditions. Expert Opin Biol Ther 2015; 15: 1623–1632.
Google Scholar | Crossref | Medline37. Yang, M, Sun, JY, Ying, CC, et al. Adipose-derived stem cells modified by BDNF gene rescue erectile dysfunction after cavernous nerve injury. Neural Regen Res 2020; 15: 120–127.
Google Scholar | Crossref | Medline38. Lin, H, Dhanani, N, Tseng, H, et al. Nanoparticle improved stem cell therapy for erectile dysfunction in a rat model of cavernous nerve injury. J Urol 2016; 195: 788–795.
Google Scholar | Crossref | Medline39. Li, M, Lei, H, Xu, Y, et al. Exosomes derived from mesenchymal stem cells exert therapeutic effect in a rat model of cavernous nerves injury. Andrology 2018; 6: 927–935.
Google Scholar | Crossref | Medline40. Jeon, SH, Shrestha, KR, Kim, RY, et al. Combination therapy using human adipose-derived stem cells on the cavernous nerve and low-energy shockwaves on the corpus cavernosum in a rat model of post-prostatectomy erectile dysfunction. Urology 2016; 88: 226.e221–226.e22.
Google Scholar | Crossref | Medline41. Schweizer, MT, Wang, H, Bivalacqua, TJ, et al. A phase I study to assess the safety and cancer-homing ability of allogeneic bone marrow-derived mesenchymal stem cells in men with localized prostate cancer. Stem Cells Transl Med 2019; 8: 441–449.
Google Scholar | Crossref | Medline42. Bahk, JY, Jung, JH, Han, H, et al. Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases. Exp Clin Transplant 2010; 8: 150–160.
Google Scholar | Medline43. Scott, S, Roberts, M, Chung, E. Platelet-rich plasma and treatment of erectile dysfunction: critical review of literature and global trends in platelet-rich plasma clinics. Sex Med Rev 2019; 7: 306–312.
Google Scholar | Crossref | Medline44. Wu, YN, Wu, CC, Sheu, MT, et al. Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model. J Tissue Eng Regen Med 2016; 10: E294–E304.
Google Scholar | Crossref | Medline45. Sánchez, M, Anitua, E, Delgado, D, et al. Platelet-rich plasma, a source of autologous growth factors and biomimetic scaffold for peripheral nerve regeneration. Expert Opin Biol Ther 2017; 17: 197–212.
Google Scholar | Crossref | Medline46. Kushida, S, Kakudo, N, Morimoto, N, et al. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs 2014; 17: 186–192.
Google Scholar | Crossref | Medline | ISI47. Epifanova, MV, Gvasalia, BR, Durashov, MA, et al. Platelet-rich plasma therapy for male sexual dysfunction: myth or reality? Sex Med Rev 2020; 8: 106–113.
Google Scholar | Crossref | Medline48. Wu, CC, Wu, YN, Ho, HO, et al. The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model. J Sex Med 2012; 9: 2838–2848.
Google Scholar | Crossref |